H Lee Moffitt Cancer Center and Research Institute Hospital Inc is a 501(c)(3) organization based in Tampa, Florida, registered in 1994, with $2,266,093,525 in FY2023 revenue. CharityIndex grades it A, and it directs about 86% of spending to programs.
Revenue (FY2023)
$2.3B
▲ 11.9% vs prior year
Health median: $840K
Expenses (FY2023)
$1.9B
Net assets
$328.0M
Employees
6,256
Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. For H Lee Moffitt Cancer Center and Research Institute Hospital Inc: 86% to programs · $0 to raise $100 earns a A on this criterion. See the exact thresholds →
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For H Lee Moffitt Cancer Center and Research Institute Hospital Inc: 2 mo reserves · +18% margin earns a B on this criterion. See the exact thresholds →
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. For H Lee Moffitt Cancer Center and Research Institute Hospital Inc: 6 of 6 checks met earns a A+ on this criterion. See the exact thresholds →
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For H Lee Moffitt Cancer Center and Research Institute Hospital Inc: 4 of 5 disclosure signals earns a A on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
To contribute to the prevention and cure of cancer.
Revenue grew from $715.8M (FY2013) to $2.3B (FY2023) across 11 reported years.
Financial snapshot
Operating margin
17.7%
Revenue exceeded expenses in the latest fiscal year.
Total assets
$457.2M
Total liabilities
$129.1M
Net assets
$328.0M
Salaries & benefits
$631.1M
34% of expenses
Board members
16
16 independent
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2023 | $2,266,093,525▲11.9% | $1,863,950,104▲14.9% | $328,033,802▲14.4% | $457,172,681▲16.4% | 990 |
| 2022 | $2,024,751,052▲15.5% | $1,622,473,343▲15.1% | $286,725,431▲16.0% | $392,759,623▲11.6% | 990 |
| 2021 | $1,753,776,154▲14.7% | $1,409,693,924▲14.3% | $247,266,020▲30.6% | $351,948,718▲14.7% | 990 |
| 2020 | $1,529,253,212▲11.7% | $1,233,194,674▲14.1% | $189,319,358▼4.8% | $306,961,963▲7.3% | 990 |
| 2019 | $1,369,161,087▲8.5% | $1,080,580,709▲6.2% | $198,847,498▼7.4% | $286,006,622▲4.0% | 990 |
| 2018 | $1,262,183,814▲21.1% | $1,017,284,444▲16.3% | $214,815,328▲27.4% | $274,999,134▲27.4% | 990 |
| 2017 | $1,042,592,797▲12.7% | $874,970,844▲12.0% | $168,633,768▲41.3% | $215,935,906▲16.2% | 990 |
| 2016 | $925,040,784▲13.2% | $781,216,193▲11.6% | $119,343,409▲7.6% | $185,909,533▲14.7% | 990 |
| 2015 | $817,462,649▲6.9% | $700,127,638▲7.5% | $110,886,663▲28.3% | $162,071,983▲14.6% | 990 |
| 2014 | $764,956,946▲6.9% | $651,431,428▲7.4% | $86,399,145▲0.4% | $141,481,633▲4.8% | 990 |
| 2013 | $715,755,248 | $606,351,225▲7.4% | $86,049,010▲24.8% | $135,008,983▲19.8% | 990 |
| 2012 | — | $564,442,968▲0.3% | $68,926,905▼28.3% | $112,736,878▼10.5% | 990 |
| 2011 | — | $562,502,915▲10.4% | $96,083,043▲2.2% | $125,951,439▼2.8% | 990 |
| 2010 | — | $509,664,148▲10.7% | $94,052,747▼66.5% | $129,567,820▼60.1% | 990 |
| 2009 | — | $460,246,141 | $280,918,193 | $325,027,437 | 990 |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Highest-paid: G Douglas Letson — $1,073,620 (0.06% of total expenses)
| Name | Title | Hours/week | Compensation |
|---|---|---|---|
| G Douglas Letson | Evp-phys In Chief To 6/2/24 | 19 | $1,073,620 |
| Robert Keenan | Vp-chief Medical Officer To 1/20/24 | 55 | $872,224 |
| Karen Wartenberg | Vp Moffitt Medical Group | 25 | $442,172 |
| Kelly Gonzalvo | Vp Patient Care/cno | 55 | $421,985 |
| Matthew Bednar | Vp-ambulatory/virtual Care Ops | 55 | $404,616 |
| Evan Zaslow | Vp Payer Strategies | 20 | $389,889 |
| Eduardo G Moros | Sr Mbr Physicist-rad Onc | 50 | $379,461 |
| Stuart G Wasserman | Dir Clinical Physics | 50 | $373,073 |
| Vladimir Feygelman | Sr Mbr Physicist-rad Onc | 50 | $321,986 |
| Geoffrey G Zhang | Sr Mbr Physicist-rad Onc | 50 | $317,639 |
| Kenneth Komorny | Vp Chief Pharmacy Officer | 55 | $308,788 |
| Marilyn Costache | Chief Risk Officer | 55 | $267,751 |
| Tim Hembree | Vp Chief Quality Off As of 7/9/23 | 55 | $252,522 |
| Christine Alvero | Vp, Hospital Ops (mmh) As of 7/1/23 | 55 | $250,742 |
| Jane Fusilero | Frm Vp-pat Care Svs/cno To 2/5/23 | 0 | $182,869 |
| Beth A Houghton | Director, Chair | 1 | — |
| Beth Simonetti | Director To 3/1/24 | 1 | — |
| Hal Walker | Director | 1 | — |
| Henry Reyes | Vp-partnership Dev To 4/12/24 | 6 | — |
| Jennifer Moffitt | Director | 1 | — |
| Contractor | Services | Paid |
|---|---|---|
| National Marrow Donor Program | Donor Search Services | $11,878,445 |
| University Diagnostic Inst | Mri Services | $5,530,179 |
| Aya Healthcare Inc | Healthcare Staffing Services | $3,336,816 |
| Sodexo Inc & Affiliates | Food Services | $2,725,092 |
| Assoc Regional & Univ Path | Laboratory Services | $2,531,221 |
82 grants to H Lee Moffitt Cancer Center and Research Institute Hospital Inc totaling $17.9M, reported by foundations on their Schedule I filings — showing the 15 most recent.
| Grantmaker | Purpose | Year | Amount |
|---|---|---|---|
| Blood Cancer United Inc | Research grant | 2024 | $1,312,498 |
| American Cancer Society Inc | Patient support | 2024 | $10,000 |
| American Cancer Society Inc | Patient support | 2024 | $8,006 |
| Blood Cancer United Inc | Research grant | 2023 | $2,062,118 |
| American Cancer Society Inc | Extramural research grant | 2023 | $1,340,533 |
| H Lee Moffitt Cancer Center and Research Institute Inc | Intercompany support | 2023 | $469,625 |
| Johns Hopkins University | Sub-award | 2023 | $75,584 |
| Fred Hutchinson Cancer Center | Research support/subawards | 2023 | $45,425 |
| Yale University | Subaward - sponsored research | 2023 | $36,711 |
| Gulf Coast Community Foundation Inc | Health | 2023 | $34,881 |
| Vanguard Charitable Endowment Program | For recipient's exempt purpose | 2023 | $23,000 |
| Donor Advised Charitable Giving | Health | 2023 | $20,900 |
| Fidelity Investments Charitable Gift Fund | For grant recipient's exempt purposes | 2023 | $16,600 |
| American Cancer Society Inc | Extramural research grant | 2022 | $1,011,500 |
| H Lee Moffitt Cancer Center and Research Institute Inc | Intercompany support | 2022 | $398,225 |
2 grants totaling $20.6M in FY2023. All grants made by H Lee Moffitt Cancer Center and Research Institute Hospital Inc →
| Recipient | Purpose | Amount |
|---|---|---|
| H Lee Moffitt Cancer Center and Research Institute Inc | Intercompany support | $20,596,052 |
| University of South Florida Foundation Inc | Sponsorship | $50,000 |
Explore more
Data for H Lee Moffitt Cancer Center and Research Institute Hospital Inc (EIN 59-3238634) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.